Monitoring patients receiving monoclonal antibodies (part 1)
Barnay, Camille
Monitoring patients receiving monoclonal antibodies (part 1) - 2023.
58
The growing interest in biomedicine—particularly in the form of monoclonal antibodies—in cancerology, but also in inflammatory, infectious, and autoimmune diseases, means that GPs today need to be in a position to support these patients. What questions should they be able to answer, and how should they carry out monitoring? This first part deals with general information, vaccination, and travel, while the second part looks at monitoring and the main adverse effects.
Monitoring patients receiving monoclonal antibodies (part 1) - 2023.
58
The growing interest in biomedicine—particularly in the form of monoclonal antibodies—in cancerology, but also in inflammatory, infectious, and autoimmune diseases, means that GPs today need to be in a position to support these patients. What questions should they be able to answer, and how should they carry out monitoring? This first part deals with general information, vaccination, and travel, while the second part looks at monitoring and the main adverse effects.
Réseaux sociaux